首页> 外文期刊>General Pharmacology >Buspirone, a 5-HT(1A) receptor agonist, dilates the perfused rat uterine vascular bed through alpha(1)-adrenoceptor blockade.
【24h】

Buspirone, a 5-HT(1A) receptor agonist, dilates the perfused rat uterine vascular bed through alpha(1)-adrenoceptor blockade.

机译:5-HT(1A)受体激动剂丁螺环酮通过α(1)-肾上腺素受体阻滞剂扩张灌注的大鼠子宫血管床。

获取原文
获取原文并翻译 | 示例
       

摘要

In the perfused rat uterine vascular bed, 5-hydroxytryptamine (5-HT) produced dose-dependent vasoconstrictor responses. Buspirone, a selective 5-HT(1A) receptor agonist, was not effective at low doses but produced a response at high doses. When perfusion pressure was raised with phenylephrine, responses to 5-HT were enhanced while buspirone produced dose-dependent vasodilator responses. Buspirone did not produce vasodilation when perfusion pressure was raised with vasopressin or U46619. Buspirone-induced vasodilator responses were not affected by selective 5-HT(1A) receptor antagonists, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4,5]-decane-7,9-dione (BMY 7378) and N-tert-butyl-3-(4-[2-methoxyphenyl]piperazin-1-yl)-2-phenylpropanamide (WAY 100478), indicating that specific 5-HT(1A) receptors might not be involved in buspirone-induced vasodilation. Buspirone (3 x 10 (-5) M) and prazosin (3 x 10(-9) M) antagonized noradrenaline-induced constriction with dose ratios of 19.1+/-2.9 and 11.7+/-2.1, respectively. The dose ratio of these antagonists in combination was 46.6+/-8.1. Since the combination ratio is closer to the sum of their individual dose ratios less 2 (i.e. DR(p)+DR(b)-2) than it is to the product of their individual dose ratios, our data suggest an interaction of buspirone with alpha(1)-adrenoceptors. Buspirone also protected adrenoceptors against inactivation by phenoxybenzamine confirming that buspirone interacted with alpha(1)-adrenoceptors. We concluded that buspirone-induced vasodilation of the perfused rat uterine vascular bed is mediated through blockade of alpha(1)-adrenoceptors rather than through 5-HT(1A) receptors.
机译:在灌注的大鼠子宫血管床中,5-羟色胺(5-HT)产生剂量依赖性的血管收缩反应。丁螺环酮是一种选择性5-HT(1A)受体激动剂,在低剂量时无效,但在高剂量时会产生反应。当用去氧肾上腺素提高灌注压力时,对5-HT的反应增强,而丁螺环酮产生剂量依赖性的血管舒张剂反应。当加压素或U46619升高灌注压力时,丁螺环酮不会产生血管舒张作用。丁螺环酮诱导的血管舒张反应不受选择性5-HT(1A)受体拮抗剂,8- [2- [4-(2-甲氧基苯基)-1-哌嗪基]乙基] -8-氮杂螺[4,5]-癸烷的影响-7,9-二酮(BMY 7378)和N-叔丁基-3-(4- [2- [2-甲氧基苯基]哌嗪-1-基)-2-苯基丙酰胺(WAY 100478),表明特异性5-HT(1A )受体可能不参与丁螺环酮诱导的血管舒张。丁螺环酮(3 x 10(-5)M)和哌唑嗪(3 x 10(-9)M)拮抗去甲肾上腺素引起的收缩,剂量比分别为19.1 +/- 2.9和11.7 +/- 2.1。这些拮抗剂组合的剂量比为46.6 +/- 8.1。由于组合比与其各自剂量比的乘积相比更接近其各自剂量比的总和小2(即DR(p)+ DR(b)-2),因此我们的数据表明丁螺环酮与alpha(1)-肾上腺素受体。丁螺环酮还保护肾上腺素能受体不受苯氧基苯甲胺的灭活,证实丁螺环酮与α(1)-肾上腺素能受体相互作用。我们得出的结论是,丁螺环酮诱导的灌注大鼠子宫血管床的血管舒张作用是通过阻断α(1)-肾上腺素受体而不是通过5-HT(1A)受体来介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号